Aurora Cannabis (NASDAQ:ACB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 73.68 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $48.798 million which missed the analyst consensus estimate of $50.510 million by 3.39 percent. This is a 31.09 percent decrease over sales of $70.815 million the same period last year.